Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

NGEN

NervGen Pharma Corp

Feb 06 • 04:00PM ET

3.88

+0.05 1.31 %

Healthcare • Biotechnology • Canada • NASD

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.26	Insider Own	21.82%	Shs Outstand	73.41M	Perf Week	-3.24%
Market Cap	308.81M	Forward P/E	-	EPS next Y	-0.24	Insider Trans	0.00%	Shs Float	62.23M	Perf Month	-33.56%
Enterprise Value	300.64M	PEG	-	EPS next Q	-0.04	Inst Own	0.06%	Short Float	1.96%	Perf Quarter	63.71%
Income	-18.50M	P/S	-	EPS this Y	29.46%	Inst Trans	-2.88%	Short Ratio	7.76	Perf Half Y	77.17%
Sales	0.00M	P/B	-	EPS next Y	-31.49%	ROA	-142.21%	Short Interest	1.22M	Perf YTD	-30.71%
Book/sh	-0.03	P/C	37.71	EPS next 5Y	1.68%	ROE	-790.82%	52W High	6.30 -38.41%	Perf Year	90.01%
Cash/sh	0.10	P/FCF	-	EPS past 3/5Y	-0.24% 1.73%	ROIC	-	52W Low	1.50 158.67%	Perf 3Y	140.25%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	8.26% 8.32%	Perf 5Y	97.96%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	4.53%	Oper. Margin	-	ATR (14)	0.38	Perf 10Y	-
Dividend Ex-Date	-	Quick Ratio	0.79	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	32.88	Recom	1.33
Dividend Gr. 3/5Y	- -	Current Ratio	0.79	EPS Q/Q	24.68%	SMA20	-19.50%	Beta	0.91	Target Price	6.14
Payout	-	Debt/Eq	-	Sales Q/Q	-	SMA50	-18.34%	Rel Volume	0.93	Prev Close	3.83
Employees	-	LT Debt/Eq	-	Earnings	Nov 25 BMO	SMA200	21.37%	Avg Volume	157.15K	Price	3.88
IPO	Apr 03, 2019	Option/Short	Yes / Yes	EPS/Sales Surpr.	30.10% -	Trades		Volume	145,910	Change	1.31%

Jan-20-26 07:00AM	NervGen Pharma to Ring the Nasdaq Closing Bell on January 22, 2026, Celebrating Its Recent Nasdaq Listing (GlobeNewswire) -6.93%
Jan-08-26 06:30AM	NervGen Pharma Begins Trading on Nasdaq Today (GlobeNewswire)

NervGen Pharma Corp. operates as a clinical stage biotech company. It provides development of treatment that enables the nervous system to repair itself following damage, whether due to injury or disease. The company was founded by Harold Punnett and William Joseph Radvak on January 19, 2017 and is headquartered in Vancouver, Canada.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

NGEN

NervGen Pharma Corp

Upgrade your FINVIZ experience